[Federal Register Volume 89, Number 37 (Friday, February 23, 2024)]
[Notices]
[Pages 13725-13726]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-03672]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; AREA/REAP: Musculoskeletal, Skin and Oral Sciences.
    Date: March 14, 2024.
    Time: 9:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Richard Ingraham, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD 
20892, (301) 496-8551, <a href="/cdn-cgi/l/email-protection#761f181104171e171b041e361b171f1a58181f1e58111900"><span class="__cf_email__" data-cfemail="731a1d1401121b121e011b331e121a1f5d1d1a1b5d141c05">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Musculoskeletal, Skin and Oral Sciences.
    Date: March 14-15, 2024.
    Time: 1:30 p.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Richard Ingraham, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD 
20892, (301) 496-8551, <a href="/cdn-cgi/l/email-protection#0f6661687d6e676e627d674f626e66632161666721686079"><span class="__cf_email__" data-cfemail="8ae3e4edf8ebe2ebe7f8e2cae7ebe3e6a4e4e3e2a4ede5fc">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Drug Discovery and Development.
    Date: March 18, 2024.
    Time: 8:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Bethesdan Hotel, 8120 Wisconsin Avenue, Bethesda, MD 
20814.
    Contact Person: Sergei Ruvinov, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 
20892, 301-435-1180, <a href="/cdn-cgi/l/email-protection#dcaea9aab5b2afb9ae9cbfafaef2b2b5b4f2bbb3aa"><span class="__cf_email__" data-cfemail="750700031c1b061007351606075b1b1c1d5b121a03">[email protected]</span></a>.


[[Page 13726]]


    Name of Committee: Infectious Diseases and Immunology B 
Integrated Review Group; HIV Immunopathogenesis and Vaccine 
Development Study Section.
    Date: March 18-19, 2024.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Philip Owens, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Dr., Bethesda, MD 20892, (301) 594-7394, 
<a href="/cdn-cgi/l/email-protection#b7d8c0d2d9c4c785f7d4c4c599d9dedf99d0d8c1"><span class="__cf_email__" data-cfemail="36594153584546047655454418585f5e18515940">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: The Cancer Biotherapeutics Development (CBD).
    Date: March 18-19, 2024.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC 
20037.
    Contact Person: Laurie Ann Shuman Moss, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309, 
<a href="/cdn-cgi/l/email-protection#0d616c787f6468237e6578606c6360627e7e4d636465236a627b"><span class="__cf_email__" data-cfemail="1f737e6a6d767a316c776a727e7172706c6c5f71767731787069">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Cancer Immunology and Immunotherapy I.
    Date: March 18-19, 2024.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD 
20892, 301-451-4467, <a href="/cdn-cgi/l/email-protection#5e3631293f2c3a241e333f37327030373670393128"><span class="__cf_email__" data-cfemail="254d4a524457415f6548444c490b4b4c4d0b424a53">[email protected]</span></a>.

    Name of Committee: Infectious Diseases and Immunology A 
Integrated Review Group; HIV Molecular Virology, Cell Biology, and 
Drug Development Study Section.
    Date: March 18-19, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 
20892, (301) 435-1166, <a href="/cdn-cgi/l/email-protection#f1839e949384929a9ab1928283df9f9899df969e87"><span class="__cf_email__" data-cfemail="cdbfa2a8afb8aea6a68daebebfe3a3a4a5e3aaa2bb">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 16, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-03672 Filed 2-22-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>